Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 4/20 | 0.32 |
| ▸ | TET3 | O43151 | 1/20 | 0.32 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.31 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11224200 | 0.80 | TDP1 (0.35) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL2120851 | 0.79 | ALOX15 (0.37) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL700123 | 0.79 | ALOX15 (0.37) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL2054203 | 0.79 | ALOX15 (0.37) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL1791045 | 0.77 | ALOX15 (0.35) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL15609460 | 0.77 | ALOX15 (0.35) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL6257967 | 0.77 | GRIK1 (0.35) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL6944776 | 0.77 | TSHR (0.41) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL5872871 | 0.76 | — | — | |
| SCHEMBL23754436 | 0.76 | PPARG (0.36) | ALOX15HSD17B10TET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9905855-B2 | Binder composition for non-aqueous secondary battery electrode | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2018-02-27 | — | — | US | disclosed |
| US-20160156039-A1 | BINDER COMPOSITION FOR NON-AQUEOUS SECONDARY BATTERY ELECTRODE | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20120095131-A1 | BINDER COMPOSITION FOR NON-AQUEOUS SECONDARY BATTERY ELECTRODE | TOYOCHEM CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20110123929-A1 | OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, PRODUCTION METHOD FOR THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT | FUJIFILM CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| US-7358302-B2 | Composition for light-scattering film and light-scattering film using the same | TOYO INK MFG. CO., LTD. (JP) | 2008-04-15 | — | — | US | disclosed |
| US-7041416-B2 | Photosensitive resin composition, transfer material, image forming method, color filter and producing method thereof and photomask and producing method thereof | FUJI PHOTO FILM CO., LTD. (JP) | 2006-05-09 | — | — | US | disclosed |
| US-20050130063-A1 | Composition for light-scattering film and light-scattering film using the same | TOYO INK MFG. CO., LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123929-A1 | OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, PRODUCTION METHOD FOR THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT | PPOX, CRY2, HCCS | ALOX15 605/4885HSD17B10 1003/4885TET2 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.